April 25, 2011
Neuilly-sur-Seine, France, April 25, 2011 -- The ISHEID, for ‘International Symposium on HIV & Emerging Infectious Diseases’, is the biennial world leading conference in the fields of HIV & Emerging Infectious Diseases. Organized by an independent group of recognized scientists, it is a guarantee for scientific excellence. The ISHEID provides a tremendous opportunity for partnership and exchange. The conference website, www.isheid.com, is now live.
The 2012 edition of the conference will tackle current issues on HIV research as well as financial and capacity strains facing the heath care system.
Despite major advances in diagnosis and treatment, 7000 new cases of HIV infection still occur daily around the world. This is a proof that current prevention strategies are failing and that new avenues have to be explored. On the other hand, access to care is in jeopardy, not only in developing countries but also in the developed world due to the financial crisis.
Thirty years after the beginning of the epidemic, HIV infection and AIDS represents, more than ever, an issue of access to care and human rights, meaning that a revolution involving scientists and patients is mandatory.
The 2012 ISHEID meeting will address all these issues for a world free of HIV AIDS.
About the 2012 ISHEID AIDS Conference: International Congress Center, Marseille, France, website: www.isheid.com
Contact: Alain Lafeuillade, Overcome, Blvd Paul Emile Victor, 92523, Neuilly-sur-Seine, France; Ph: +33 (0) 1 40 88 97 97; Email: email@example.com
Thirty years after the beginning of the epidemic, HIV infection and AIDS represents,
Blvd Paul Emile Victor, 92523
+33 (0) 1 40 88 97 9
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release April 25, 2011 here
News-ID: 172294 • Views: 1366
More Releases from Overcome
International AIDS 2012 Conference Based on Excellence
The next AIDS ISHEID 2012 conference announced to be held in Marseilles, France, is a timely measure and is capable of bringing about a revolution. Neuilly-sur-Seine, FR, May 30, 2011 -- The Human Immunodeficiency Virus (HIV) has been ravaging the planet ever since it first infused itself into the body of the first human prey. Amongst the numerous efforts initiated towards fighting this deadly virus, ISHEID (International Symposium HIV & Emerging
HIV AIDS Biennial International Conference Ready For 2012
Neuilly-sur-Seine, France, May 06, 2011 -- The International Symposium of HIV and Emerging Infectious Diseases (ISHEID) Congress is announcing its HIV AIDS 2012 conference, to be held in Marseille, France from May 23 to May 25, 2012. This is an important conference -a "meeting of the minds" if you will- consisting of some of the top researchers and scientists in the field of HIV research and care. Abstracts will be
Monthly Leaders Interviews in Preparation of the HIV AIDS 2012 Conference
The next biennial ISHEID Conference will attract the world leading HIV AIDS experts in Marseille, France, May 23-25, 2012. The Steering Committee has just announced the conference theme: ‘From HIV Testing to HIV Cure’. Meanwhile, monthly interviews of international key opinion leaders will be published on the conference website at http://www.isheid.com/en/committees/interview.html Neuilly-sur-Seine, France, May 04, 2011 -- HIV currently infects 33 million individuals worldwide and kills 2 million people annually. In
International HIV AIDS 2012 Conference Topics
Neuilly-sur-Seine, France, April 26, 2011 -- The main theme of the 2012 HIV AIDS ISHEID Conference has just been announced: 'From HIV Testing to Cure'. This biennial international AIDS conference will take place next time in Marseille, France, May 23-25, 2012. “Despite major advances in the past 25 years, HIV infection remains a global threat with major scientific, societal and human challenges ahead”, declared Alain Lafeuillade, chair of the meeting. This
More Releases for HIV
Global HIV Market to 2024
The HIV market was valued at $16bn in 2015 and is forecast to expand at a CAGR of 3.7% between 2015 and 2024, culminating in 2024 global sales of $23bn.The expected arrival of new classes of therapies could result in a paradigm shift in the treatment of HIV treatment. Globally, around 35 million people are infected with HIV. Approximately 3 million people in the U.S and 2.5 million in top 5
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Global HIV Infection Pipeline Analysis
The discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retrovirals in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have
Global HIV Therapeutics Market
The HIV Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral